EU Revising Supply Chain, Records and Openness Requirements
This article was originally published in The Gold Sheet
Executive Summary
The European Commission’s Directorate-General for Health and Consumer Affairs has launched consultation processes on revisions to its GMP guidelines as part of an effort to strengthen the supply chain of drug products marketed in the European Union.